FKDNX
Price
$208.38
Change
+$0.62 (+0.30%)
Updated
Sep 30 closing price
Net Assets
29.39B
GFACX
Price
$74.78
Change
-$0.05 (-0.07%)
Updated
Sep 30 closing price
Net Assets
338.33B
Interact to see
Advertisement

FKDNX vs GFACX

Header iconFKDNX vs GFACX Comparison
Open Charts FKDNX vs GFACXBanner chart's image
Franklin DynaTech A
Price$208.38
Change+$0.62 (+0.30%)
VolumeN/A
Net Assets29.39B
American Funds Growth Fund of Amer C
Price$74.78
Change-$0.05 (-0.07%)
VolumeN/A
Net Assets338.33B
FKDNX vs GFACX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FKDNX vs. GFACX commentary
Oct 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FKDNX is a StrongBuy and GFACX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 338B vs. FKDNX (29.4B). FKDNX (0.00) and GFACX (0.00) have matching dividends . FKDNX was incepted earlier than GFACX: FKDNX (58 years) vs GFACX (25 years). GFACX (1.36) is less costly to investors than FKDNX (0.79). GFACX is a more actively managed with annual turnover of: 25.00 vs. FKDNX (11.94). GFACX has a lower initial minimum investment than FKDNX: GFACX (250) vs FKDNX (1000). FKDNX annual gain was more profitable for investors over the last year : 24.48 vs. GFACX (11.23). FKDNX return over 5 years is better than : 69.84 vs. GFACX (33.92).
FKDNXGFACXFKDNX / GFACX
Total Expense Ratio0.791.3658%
Annual Report Gross Expense Ratio0.791.3658%
Fund Existence58 years25 years-
Gain YTD17.92017.284104%
Front Load6%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets29.4B338B9%
Annual Yield % from dividends0.000.00-
Returns for 1 year24.4811.23218%
Returns for 3 years121.9267.97179%
Returns for 5 years69.8433.92206%
Returns for 10 years336.7886.53389%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
COEP17.460.95
+5.75%
Coeptis Therapeutics Holdings Inc
RKDA3.470.03
+0.87%
Arcadia Biosciences
SWKS76.980.05
+0.06%
Skyworks Solutions
EQV10.38-0.01
-0.10%
EQV Ventures Acquisition Corp
NN14.30-0.48
-3.25%
NextNav